You are on page 1of 1

6890 Federal Register / Vol. 70, No.

26 / Wednesday, February 9, 2005 / Notices

working closely with stakeholders and recommendations to the agency on a.m. on March 18, 2005. Time allotted
maximizing the availability and clarity FDA’s regulatory issues. for each presentation may be limited.
of information to stakeholders and the Date and Time: The meeting will be Those desiring to make formal oral
public. This is consistent with the held on March 17, 2005, from 8 a.m. to presentations should notify the contact
purposes of the Small Business 5:30 p.m., and on March 18, 2005, from person before March 9, 2005, and
Representative Program, which are in 8:30 a.m. to 2:30 p.m. submit a brief statement of the general
part to respond to industry inquiries, Location: Holiday Inn Gaithersburg, 2 nature of the evidence or arguments
develop educational materials, sponsor Montgomery Village Ave., Gaithersburg, they wish to present, the names and
workshops and conferences to provide MD. addresses of proposed participants, and
firms, particularly small businesses, Contact Person: William Freas or an indication of the approximate time
with firsthand working knowledge of Pearline K. Muckelvene, Center for requested to make their presentation.
FDA’s requirements and compliance Biologics Evaluation and Research Closed Committee Deliberations: On
policies. This workshop is also (HFM–71), Food and Drug March 18, 2005, between 1:30 p.m. and
consistent with the Small Business Administration, 1401 Rockville Pike, 2:30 p.m., the meeting will be closed to
Regulatory Enforcement Fairness Act of Rockville, MD 20852, 301–827–0314, or permit discussion where disclosure
1996 (Public Law 104–121), as outreach FDA Advisory Committee Information would constitute a clearly unwarranted
activities by Government agencies to Line, 1–800–741–8138 (301–443–0572 invasion of personal privacy (5 U.S.C.
small businesses. in the Washington, DC area), code 552b(c)(6)). The committee will discuss
The goal of this public workshop is to 3014519516. Please call the Information the site visit report for the Laboratory of
present information that will enable Line for up-to-date information on this Molecular Virology, Division of
manufacturers and regulated industry to meeting. Emerging and Transfusion Transmitted
better comply with labeling Agenda: On March 17, 2005, the Diseases, Office of Blood Research and
requirements, especially in light of committee will hear updates on the Review, Center for Biologics Evaluation
growing concerns about obesity and following topics: Summary of the and Research.
food allergens. Information presented Department of Health and Human Persons attending FDA’s advisory
will be based on agency position as Services Advisory Committee on Blood committee meetings are advised that the
Safety and Availability meeting, agency is not responsible for providing
articulated through regulation,
summary of the Transmissible access to electrical outlets.
compliance policy guides, and
Spongiform Encephalopathies Advisory FDA welcomes the attendance of the
information previously made available
Committee meeting, update on West public at its advisory committee
to the public. Topics to be discussed at
Nile Virus guidance, and summaries of meetings and will make every effort to
the workshop include: (1) Mandatory
the Critical Path Initiative workshop. In accommodate persons with physical
label elements, (2) nutrition labeling
the morning, the committee will also disabilities or special needs. If you
requirements, (3) health and nutrition
discuss and provide recommendations require special accommodations due to
claims, (4) FDA’s allergen declaration
on the safety of albumin. In the
policy, and (5) special labeling issues a disability, please contact William
afternoon, the committee will hear
such as exemptions. FDA expects that Freas or Pearline K. Muckelvene at least
additional updates on the following
participation in this public workshop 7 days in advance of the meeting.
topics: International agreements, and a Notice of this meeting is given under
will provide regulated industry with presentation on sharing information
greater understanding of the regulatory the Federal Advisory Committee Act (5
with the public. Additionally, the
and policy perspectives on food labeling U.S.C. app. 2).
committee will hear presentations, and
and increased voluntary compliance. discuss and provide recommendations Dated: February 1, 2005.
Dated: February 2, 2005. on rapid freezing of plasma for Sheila Dearybury Walcoff,
Jeffrey Shuren, transfusion. On the morning of March Associate Commissioner for External
Assistant Commissioner for Policy. 18, 2005, the committee will hear Relations.
[FR Doc. 05–2450 Filed 2–8–05; 8:45 am] presentations, and discuss and provide [FR Doc. 05–2452 Filed 2–8–05; 8:45 am]
recommendations on the study design BILLING CODE 4160–01–S
for the abbreviated uniform donor
history questionnaire. The committee
DEPARTMENT OF HEALTH AND also will hear presentations related to DEPARTMENT OF HEALTH AND
HUMAN SERVICES the review of the site visit report for the HUMAN SERVICES
Laboratory of Molecular Virology,
Food and Drug Administration Division of Emerging and Transfusion Health Resources and Services
Transmitted Diseases, Office of Blood Administration
Blood Products Advisory Committee; Research and Review.
Notice of Meeting Procedure: On March 17, 2005, from Chiropractor Loan Repayment
8 a.m. to 5:30 p.m., and on March 18, Demonstration Project
AGENCY: Food and Drug Administration,
HHS. 2005, from 8:30 a.m. to 12:30 p.m., the AGENCY: Health Resources and Services
meeting is open to the public. Interested Administration (HRSA), HHS.
ACTION: Notice.
persons may present data, information, ACTION: General notice.
This notice announces a forthcoming or views, orally or in writing, on issues
meeting of a public advisory committee pending before the committee. Written SUMMARY: The authority for the
of the Food and Drug Administration submissions may be made to the contact Demonstration Project has been
(FDA). At least one portion of the person by February 25, 2005. Oral extended with respect to chiropractors
meeting will be closed to the public. presentations from the public will be (see legislative authority below). The
Name of Committee: Blood Products scheduled between approximately 11 Health Resources and Services
Advisory Committee. a.m. and 12 noon, and 3:30 p.m. and Administration (HRSA) announces that
General Function of the Committee: 4:45 p.m. on March 17, 2005, and applications from qualified
To provide advice and between approximately 9:30 a.m. and 10 chiropractors who agree to serve

VerDate jul<14>2003 16:49 Feb 08, 2005 Jkt 205001 PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 E:\FR\FM\09FEN1.SGM 09FEN1